Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary Disease

Clinical trial NCT02573870 · COMPLETED

Trial details

NCT number: NCT02573870
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Pulmonary Disease, Chronic Obstructive

Start date: 2015-12-01
Primary completion: 2016-07-05
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.